AI devices: revolutionizing sepsis patient care

SpassMed, a Canadian innovator at the forefront of AI in healthcare, specializes in AI-driven medical devices. Its AI-based sepsis diagnosis solution, FDA-cleared in 2023, interprets vital signs to provide actionable insights for sepsis management – a condition with high mortality rates. Integrating with global monitoring systems like Philips and GE Healthcare, this Generative AI technology enhances patient care, enables healthcare professionals to manage multiple patients effectively and reduces costs in understaffed hospitals.

Dedicated to developing simple, efficient and cost-effective AI solutions, SpassMed is committed to revolutionizing patient care and advancing clinical decision-making in the healthcare industry.

  • Founded: 2020
  • Staff: 8
  • Annual sales (USD): Pre-revenue
SpassMed Inc. logo



Event details

Date: March 10 - 13, 2024

Event contact

Mauricio Ospina
Area Director
USA: Information and Communications Technology and Automotive


7 in total